Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Theresa K. Wolf-Doty
Observed names:
T. Wolf-Doty,
Theresa Wolf-Doty,
Theresa Wolf‐Doty
Institution:
CareDx, Inc. (United States)
Observed institutions:
NewYork–Presbyterian Hospital,
Columbia University Irving Medical Center,
CareDx, Inc. (United States),
Columbia University
ORCID:
0000-0002-4725-3385
Observed ORCID:
0000-0002-4725-3385
OpenAlex ID:
A5064396959
Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study
2021
·
Lihong Bu
, Gaurav Gupta
, et al.
·
Kidney International
·
204
PDF
Dynamic Response of Donor-Derived Cell-Free DNA Following Treatment of Acute Rejection in Kidney Allografts
2021
·
Theresa K. Wolf-Doty
, Roslyn B. Mannon
, et al.
·
Kidney360
·
40
Relationship between donor-derived cell-free DNA and tissue-based rejection-related transcripts in heart transplantation
2024
·
Dae Hyun Lee
, Ahsan Usmani
, et al.
·
The Journal of Heart and Lung Transplantation
·
18
PDF
KidneyCare Guided Immuno-Optimization in Renal Allografts: The KIRA Protocol
2020
·
Jennifer N. Gray
, Theresa Wolf-Doty
, et al.
·
Methods and Protocols
·
15
PDF
Gene expression profiling scores in dual organ transplant patients are similar to those in heart-only recipients
2018
·
Sandra A. Carey
, Kristen M. Tecson
, et al.
·
Transplant Immunology
·
10
Relationship between blood and tissue-based rejection-related transcripts in heart transplantation
2023
·
Dae Hyun Lee
, Ahsan Usmani
, et al.
·
The Journal of Heart and Lung Transplantation
·
9
Lack of Association Between Donor‐Derived Cell‐Free DNA and Cardiac Allograft Vasculopathy
2024
·
Rami Alharethi
, Stacey Knight
, et al.
·
Clinical Transplantation
·
6
PDF
Donor Derived Cell Free DNA as a Risk Factor for Initiating De-Novo Donor Specific Antibodies in Heart Transplantation
2021
·
E.C. DePasquale
, J. Kobashigawa
, et al.
·
The Journal of Heart and Lung Transplantation
·
5
PDF
(542) Path to Eliminating Surveillance Endomyocardial Biopsies in Heart Transplant: Early Use of Donor Derived Cell-Free DNA - One Year Follow Up
2023
·
D. Miklin
, K. Ravi
, et al.
·
The Journal of Heart and Lung Transplantation
(996) Relationship Between Absolute Quantification of Donor-Derived Cell-Free DNA and Donor-Derived Cell-Free DNA Fraction for Detection of Allograft Rejection in Heart Transplant Patients
2023
·
S. Patel
, N. Uriel
, et al.
·
The Journal of Heart and Lung Transplantation
The Impact of Grade 1R Endomyocardial Biopsies on Donor-Derived Cell-Free DNA, Higher-Grade Rejection and Development of Donor Specific Antibodies
2021
·
A. Kao
, D. Baran
, et al.
·
The Journal of Heart and Lung Transplantation
PDF
Association of Donor Age and Plasma Donor-Derived Cell-Free DNA Levels with CAV Development after Heart Transplant: SHORE Preliminary Data
2021
·
N. Raval
, A. Ravichandran
, et al.
·
The Journal of Heart and Lung Transplantation
Gene Expression Profiling for Cardiac Transplant Recipients: Results from the Outcomes AlloMap® Registry
2018
·
S.A. Hall
, G. Ewald
, et al.
·
The Journal of Heart and Lung Transplantation
Show more works
View as search
Works count:
13
Citation count:
307
H-index:
6
I10-index:
5
Year
Topic
Type